Cigna Corp (N:CI)

Business Focus: Managed Health Care

Sector:  Healthcare Industry:  Managed Health Care
See Regulatory Filings on SEC
Company Contact
Address: 900 Cottage Grove Rd
BLOOMFIELD CT 06002-2920
Tel: 1-215-7614198
IR: See website
Key People
Isaiah Harris
Independent Chairman of the Board
Lisa R. Bacus
Executive Vice President, Chief Marketing Officer,Chief Customer Officer
David M. Cordani
President, Chief Executive Officer, Director
Eric P. Palmer
Chief Financial Officer, Executive Vice President
Brian C. Evanko
President - Government Business
Matthew G. Manders
President - Strategy and Solutions
Jason Dominic Sadler
President - International Markets
Michael W Triplett
President - U.S. Markets
Timothy Charles Wentworth
President - Health Services
Mark L. Boxer
Executive Vice President, Chief Information Officer
Business Overview
Cigna Corporation is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company's segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate. Its Global Health Care segment aggregates the commercial and Government operating segments. Its commercial operating segment encompasses the United States commercial and certain international healthcare businesses serving employers and their employees, other groups, and individuals. Its Global Supplemental Benefits segment offers supplemental health, life and accident insurance products in selected international markets and in the United States. Its Group Disability and Life segment provides group long-term and short-term disability insurance, group life insurance, accident and specialty insurance and related services.
Financial Overview
For the six months ended 30 June 2019, Cigna Corp revenues increased from $22.86B to $76.8B. Net income increased 61% to $2.78B. Revenues reflect Health Services segment increase from $2.18B to $54.94B. Net income was partially offset by GAAP Expense Ratio - % Global supplement increase of 1% to 32.1%, Pharmacy and other service costs increase from $1.17B to $49.01B (expense).
Employees: 73,800 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $96,569M as of Jun 30, 2019
Annual revenue (TTM): $102,492M as of Jun 30, 2019
EBITDA (TTM): $8,397M as of Jun 30, 2019
Net annual income (TTM): $3,690M as of Jun 30, 2019
Free cash flow (TTM): $4,176M as of Jun 30, 2019
Net Debt Last Fiscal Year: $35,585M as of Jun 30, 2019
Shares outstanding: 377,609,272 as of Jul 15, 2019
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization